Dynamix Pharmaceuticals

Developing small molecule kinase II inhibitors for cancer and autoimmune diseases

placeRehovot, Central District, Israel calendar_todayFounded 2009 groups11 employees language dynxp.com

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%
Coming soon